MOG and myeloid sarcoma: Seven Dutch patients included in the POMS group had an unknown or inconclusive MOG-ab status; however, none of these patients was qualified as typical MOG-ab associated disorder; six patients had a typical clinical and radiological MS disease course, and one patient was diagnosed with tumefactive MS.